328 related articles for article (PubMed ID: 17287073)
1. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
Kawai Y; Sakano S; Korenaga Y; Eguchi S; Naito K
Eur Urol; 2007 Oct; 52(4):1147-55. PubMed ID: 17287073
[TBL] [Abstract][Full Text] [Related]
2. Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival.
Dassoulas K; Gazouli M; Rizos S; Theodoropoulos G; Christoni Z; Nikiteas N; Karakitsos P
Mol Carcinog; 2009 Jun; 48(6):563-9. PubMed ID: 19009560
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival.
Tzanakis N; Gazouli M; Rallis G; Giannopoulos G; Papaconstantinou I; Theodoropoulos G; Pikoulis E; Tsigris C; Karakitsos P; Peros G; Nikiteas N
J Surg Oncol; 2006 Dec; 94(7):624-30. PubMed ID: 17111394
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.
Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T
Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089
[TBL] [Abstract][Full Text] [Related]
5. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.
Al-Moundhri MS; Al-Nabhani M; Burney IA; Al-Farsi AA; Al-Bahrani B
Mol Carcinog; 2009 Dec; 48(12):1170-6. PubMed ID: 19676106
[TBL] [Abstract][Full Text] [Related]
6. Editorial Comment on: Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
Staehler M
Eur Urol; 2007 Oct; 52(4):1155. PubMed ID: 17287072
[No Abstract] [Full Text] [Related]
7. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.
Jin Q; Hemminki K; Enquist K; Lenner P; Grzybowska E; Klaes R; Henriksson R; Chen B; Pamula J; Pekala W; Zientek H; Rogozinska-Szczepka J; Utracka-Hutka B; Hallmans G; Försti A
Clin Cancer Res; 2005 May; 11(10):3647-53. PubMed ID: 15897560
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.
Kim JG; Chae YS; Sohn SK; Cho YY; Moon JH; Park JY; Jeon SW; Lee IT; Choi GS; Jun SH
Clin Cancer Res; 2008 Jan; 14(1):62-6. PubMed ID: 18172253
[TBL] [Abstract][Full Text] [Related]
9. Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer.
Masago K; Fujita S; Kim YH; Hatachi Y; Fukuhara A; Nagai H; Irisa K; Ichikawa M; Mio T; Mishima M
Cancer Sci; 2009 Oct; 100(10):1917-22. PubMed ID: 19594543
[TBL] [Abstract][Full Text] [Related]
10. CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value.
Liang YX; He HC; Han ZD; Bi XC; Dai QS; Ye YK; Qin WJ; Zeng GH; Zhu G; Xu CL; Zhong WD
Cancer Invest; 2009 Aug; 27(7):788-93. PubMed ID: 19548138
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer.
Hefler LA; Mustea A; Könsgen D; Concin N; Tanner B; Strick R; Heinze G; Grimm C; Schuster E; Tempfer C; Reinthaller A; Zeillinger R
Clin Cancer Res; 2007 Feb; 13(3):898-901. PubMed ID: 17289883
[TBL] [Abstract][Full Text] [Related]
12. Predictive role of vascular endothelial growth factor polymorphisms in the survival of renal cell carcinoma patients.
Yang YQ; Chen J
Genet Mol Res; 2014 Jul; 13(3):5011-7. PubMed ID: 25062489
[TBL] [Abstract][Full Text] [Related]
13. Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome.
Sfar S; Hassen E; Saad H; Mosbah F; Chouchane L
Cytokine; 2006 Jul; 35(1-2):21-8. PubMed ID: 16908180
[TBL] [Abstract][Full Text] [Related]
14. The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer.
Hirata H; Hinoda Y; Nakajima K; Kikuno N; Suehiro Y; Tabatabai ZL; Ishii N; Dahiya R
J Urol; 2009 Aug; 182(2):721-7. PubMed ID: 19539330
[TBL] [Abstract][Full Text] [Related]
15. VEGF polymorphisms are associated with an increasing risk of developing renal cell carcinoma.
Bruyère F; Hovens CM; Marson MN; d'Arcier BF; Costello AJ; Watier H; Linassier C; Ohresser M
J Urol; 2010 Oct; 184(4):1273-8. PubMed ID: 20723915
[TBL] [Abstract][Full Text] [Related]
16. VEGF and VEGFR-1 are coexpressed by epithelial and stromal cells of renal cell carcinoma.
Rivet J; Mourah S; Murata H; Mounier N; Pisonero H; Mongiat-Artus P; Teillac P; Calvo F; Janin A; Dosquet C
Cancer; 2008 Jan; 112(2):433-42. PubMed ID: 18041056
[TBL] [Abstract][Full Text] [Related]
17. Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients.
Sáenz-López P; Carretero R; Vazquez F; Martin J; Sánchez E; Tallada M; Garrido F; Cózar JM; Ruiz-Cabello F
Hum Immunol; 2010 Mar; 71(3):309-13. PubMed ID: 19961892
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis.
Kang S; Zhao J; Liu Q; Zhou R; Wang N; Li Y
Environ Mol Mutagen; 2009 Jun; 50(5):361-6. PubMed ID: 19197986
[TBL] [Abstract][Full Text] [Related]
19. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.
Ljungberg BJ; Jacobsen J; Rudolfsson SH; Lindh G; Grankvist K; Rasmuson T
BJU Int; 2006 Sep; 98(3):661-7. PubMed ID: 16925769
[TBL] [Abstract][Full Text] [Related]
20. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]